SRXN1 and hepatocellular carcinoma: Moreover, we found that high expression of SRXN1 was correlated with poor prognosis (low rates of overall survival and disease‐free survival) of HCC patients in both the TCGA data (Figure 1E,F) and our collected tissue samples (Figure 1G,H).